Delayed massive pulmonary thromboembolic phenomenon following envenomation by Mojave rattlesnake (Crotalus scutulatus)

Thrombosis and Haemostasis

Volumn 104, Issue 1, 2010, Pages 186-188

  Bhagat, Ramesh ^a   Sharma, Kapil ^b   Sarode, Ravi ^a   Shen, Yu Min ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROFAB; D DIMER; FIBRINOGEN; HEPARIN; SNAKE VENOM; SNAKE VENOM ANTISERUM; UNCLASSIFIED DRUG; WARFARIN;

ADULT; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL ASSESSMENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CRYOPRECIPITATE; ENDOTRACHEAL INTUBATION; ENVENOMATION; FOLLOW UP; HOSPITALIZATION; HUMAN; LETTER; LUNG EMBOLISM; MALE; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; TREATMENT OUTCOME; VITAL SIGN;

ANIMALS; ANTIVENINS; CROTALID VENOMS; CROTALUS; HEMORRHAGIC DISORDERS; HUMANS; INTUBATION, INTRATRACHEAL; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RESPIRATION, ARTIFICIAL; SNAKE BITES;

EID: 77954364405     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-12-0874     Document Type: Letter

References (16)

1. Castro HC, Zingali RB, Albuquerque MG, et al. Snake venom thrombin-like enzymes: from reptilase to now. Cell Mol Life Sci 2004; 61: 843-856.
2. Markland FS. Snake venoms and the hemostatic system. Toxicon 1998; 36: 1749-1800.
3. Matsui T, Fujimura Y, Titani K. Snake venom proteases affecting hemostasis and thrombosis. Biochim Biophys Acta 2000; 1477: 146-156.
4. Clark RF, Williams SR, Nordt SP, et al. Successful treatment of crotalid-induced neurotoxicity with a new polyspecific crotalid Fab antivenom. Ann Emerg Med 1997; 30: 54-57.
5. Bronstein AC, Spyker DA, Cantilena LR, Jr., et al. 2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS). Clin Toxicol 2007; 45: 815-917.
6. Glenn JL, Straight RC. Intergradation of two different venom populations of the Mojave rattlesnake (Crotalus scutulatus scutulatus) in Arizona. Toxicon 1989; 27: 411-418.
7. Glenn JL, Straight RC, Wolfe MC, Hardy DL. Geographical variation in Crotalus scutulatus scutulatus (Mojave rattlesnake) venom properties. Toxicon 1983; 21: 119-130.
8. Bush SP, Cardwell MD. Mojave rattlesnake (Crotalus scutulatus scutulatus) identification. Wilderness Environ Med 1999; 10: 6-9.
9. Farstad D, Thomas T, Chow T, et al. Mojave rattlesnake envenomation in southern California: a review of suspected cases. Wilderness Environ Med 1997; 8: 89-93.
10. Hardy DL. Envenomation by the Mojave rattlesnake (Crotalus scutulatus scutulatus) in southern Arizona, U.S.A. Toxicon 1983; 21: 111-118.
11. Jansen PW, Perkin RM, Van Stralen D. Mojave rattlesnake envenomation: prolonged neurotoxicity and rhabdomyolysis. Ann Emerg Med 1992; 21: 322-325.
12. Hasiba U, Rosenbach LM, Rockwell D, et al. DiC-like syndrome after envenomation by the snake, Crotalus horridus horridus. N Engl J Med 1975; 292: 505-507.
13. Pirkle H, Theodor I, Miyada D, et al. Thrombin-like enzyme from the venom of Bitis gabonica. Purification, properties, and coagulant actions. J Biol Chem 1986; 261: 8830-8835.
14. Dempfle CE, Kohl R, Harenberg J, et al. Coagulopathy after snake bite by Bothrops neuwiedi: case report and results of in vitro experiments. Blut 1990; 61: 369-374.
15. Seifert SA, Boyer LV. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies. Ann Emerg Med 2001; 37: 189-195.
16. Boyer LV, Seifert SA, Clark RF, et al. Recurrent and persistent coagulopathy following pit viper envenomation. Arch Intern Med 1999; 159: 706-710.